ACAD: ACADIA Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,998.84
Enterprise Value ($M) 2,559.98
Book Value ($M) 431.75
Book Value / Share 2.62
Price / Book 6.95
NCAV ($M) 298.92
NCAV / Share 1.81
Price / NCAV 10.03

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.10
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 2.28
Current Ratio 2.42

Balance Sheet (mrq) ($M)
Current Assets 616.12
Assets 748.96
Liabilities 317.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 726.44
Operating Income -73.38
Net Income -61.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 16.70
Cash from Investing 32.00
Cash from Financing 25.13

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Rtw Investments, Lp 6.90
02-13 13G/A Vanguard Group Inc 8.16 0.88
02-09 13G/A Fmr Llc 3.21 -43.59
01-26 13G/A BlackRock Inc. 6.90 11.21
05-24 13D/A Baker Bros. Advisors Lp 26.50 2.18

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 178,694 1,318,298 13.55
2024-03-26 165,022 1,445,409 11.42
2024-03-25 498,477 1,845,162 27.02
2024-03-22 159,629 1,480,951 10.78

(click for more detail)

Similar Companies
ABCL – AbCellera Biologics Inc. ABOS – Acumen Pharmaceuticals, Inc.
ABUS – Arbutus Biopharma Corporation ACLX – Arcellx, Inc.
ACOR – Acorda Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: ACADIA Pharmaceuticals